Neuropharmacological Treatment of Mental Dysfunction in Parkinson’s Disease
Many patients with Parkinson's Disease (PD) experience significant cognitive and mood impairment -even early in the course of the disease. These mental impairments are only partially responsive to levodopa treatment and are often as disabling as the motor impairment, particularly in mid and lat...
Main Authors: | Patrick McNamara, Raymon Durso |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2006-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.1155/2006/138263 |
Similar Items
-
Side of Onset in Parkinson’s Disease and Alterations in Religiosity: Novel Behavioral Phenotypes
by: Paul M. Butler, et al.
Published: (2011-01-01) -
Neuropharmacologic Approaches to Cognitive Rehabilitation
by: Reva Klein, et al.
Published: (2006-01-01) -
The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates
by: Patrick McNamara, et al.
Published: (2010-01-01) -
The non dopaminergic neuropharmacology of idiopathic Parkinson's disease
by: Foy, Catherine Mary Louise
Published: (2000) -
On-off fluctuations in Parkinson's disease : a clinical and neuropharmacological study
by: Hardie, R. J.
Published: (1985)